According to WHO, Osteoporosis is second only to cardiovascular disease as a global healthcare problem. International Osteoporosis Foundation (IOF) estimates that the annual direct cost of treating osteoporosis fractures of people in the workplace in the USA, Canada and Europe alone is approximately USD48 billion. The present study comprises of clinically, diagnostically confirmed cases of Postmenopausal Osteoporosis both Diabetics and NonDiabetics and attending the orthopaedic unit of KLES Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi. All the cases were evaluated and selected by simple random technique after fulfilling the selection criteria. The cases of Osteoporosis reported to the Department of Orthopaedics unit of KLES Hospital and Medical Research Center were screened. After finding the suitability as per selection criteria they were requested to participate in the study and briefed about the nature of the study and interventions used. The mean serum calcium for diabetics was 8.22±1.13 mg/dL and for non-diabetics was 8.4 ± 1.27 mg/Dl. The mean serum calcium levels were lower in Diabetics but was not statistically significant (p=0.5564 for calcium)